Ida Christine Jacobsen

ORCID

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Venues

Acta oncologica (Stockholm, Sweden)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Simon Birk Kjær Jensen, Charlotte Janus, Julie Rehné Lundgren, Christian Rimer Juhl, Rasmus Michael Sandsdal, Lisa Møller Olsen, Anne Andresen, Signe Amalie Borg, Ida Christine Jacobsen, Graham Finlayson, Bente Merete Stallknecht, Jens Juul Holst, Sten Madsbad, Signe Sørensen Torekov
Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment. Nature communications 13 (1) (2022)
Ida Christine Jacobsen, Iben Spanggaard, Martin Højgaard, Laïla Belcaid, Camilla Qvortrup, Christina Westmose Yde, Ane Yde Schmidt, Finn Cilius Nielsen, Gro Linno Willemoe, Mikkel Seidelin Dam, Ulrik Lassen, Kristoffer Staal Rohrberg
Extensive genomic analysis in patients with KRAS -mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact. Acta oncologica (Stockholm, Sweden) (2022)
Ida Christine Jacobsen, Iben Spanggaard, Martin Højgaard, Laïla Belcaid, Camilla Qvortrup, Christina Westmose Yde, Ane Yde Schmidt, Finn Cilius Nielsen, Gro Linno Willemoe, Mikkel Seidelin Dam, Ulrik Lassen, Kristoffer Staal Rohrberg
Extensive genomic analysis in patients with KRAS -mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact. Acta oncologica (Stockholm, Sweden) 61 (12) (2022)
Ida Christine Jacobsen, Iben Spanggaard, Martin Højgaard, Laïla Belcaid, Camilla Qvortrup, Christina Westmose Yde, Ane Yde Schmidt, Finn Cilius Nielsen, Gro Linno Willemoe, Mikkel Seidelin Dam, Ulrik Lassen, Kristoffer Staal Rohrberg
Extensive genomic analysis in patients with KRAS -mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact. Acta oncologica (Stockholm, Sweden) (2022)
Ida Christine Jacobsen, Iben Spanggaard, Martin Højgaard, Laïla Belcaid, Camilla Qvortrup, Christina Westmose Yde, Ane Yde Schmidt, Finn Cilius Nielsen, Gro Linno Willemoe, Mikkel Seidelin Dam, Ulrik Lassen, Kristoffer Staal Rohrberg
Extensive genomic analysis in patients with KRAS -mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact. Acta oncologica (Stockholm, Sweden) 61 (12) (2022)

Ida Christine Jacobsen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ida Christine Jacobsen